
Innovation
Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms
Abstract Multiple studies have demonstrated that diffuse large B-cell lymphoma (DLBCL) can be divided into subgroups based on their biology; however, these biological subgroups overlap